期刊文献+

纳米凝胶载体系统的研究进展 被引量:8

Research Progress in Nanogel Carrier Systems
原文传递
导出
摘要 纳米凝胶具有粒径小、血液循环时间长、生物相容性好、生物可降解、载药量高等优点。通常用于制备纳米凝胶的载体材料有聚丙烯酸及聚丙烯酰胺类、普朗尼克类、聚多糖类高分子材料及其衍生物,可通过基于氨基的交联、"click"反应交联、物理交联、光交联、多相单体聚合等方法形成纳米凝胶。纳米凝胶作为一种理想的新型给药系统在化疗药物、蛋白类药物及基因的递送等方面显示出广阔的应用前景。笔者参考近期相关文献,对纳米凝胶的常用载体材料,制备方法及应用进行整理与总结。 Nanogels combine the advantages of hydrogels and nanoparticles, such as small particle size, prolonged blood circulation time, biocompatibility, biodegradation and high drug loading. Common carrier materials is used for the preparation of nanogels include polyacrylic acid, polyacrylamide, pluronic, polysaccharide and their derivates. They can be cross-linked based on amine reaction, "click" chemistry, photo-induced cross-linking, physical cross-linking or heterogeneous polymerization of monomers to form nanogel carrier systems. Nanogels, as ideal and novel drug delivery systems, have great promise in the delivery of chemotherapeutic drugs, proteins and genes. The carrier materials, preparation methods and applications of nanogels were reviewed based on relevant articles published in recent years.
作者 李霏霏 张娜
机构地区 山东大学药学院
出处 《中国药学杂志》 CAS CSCD 北大核心 2016年第3期177-182,共6页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(81573368)
关键词 纳米凝胶 载体材料 制备方法 药物递送 nanogel carrier material preparation method drug delivery
  • 相关文献

参考文献40

  • 1MERINO S,MARTIN C,KOSTARELOS K,et al. Nanocomposite hydrogels:3D Polymer-nanoparticle synergies for on-demand drug delivery [J]. ACS Nano,2015,9 (5):4686-4697.
  • 2HAMIDI M,AZADI A,RAFIEI P. Hydrogel nanoparticles in drug delivery [J]. Adv Drug Deliv Rev,2008,60 (15):1638-1649.
  • 3AHMED E M. Hydrogel:Preparation,characterization,and applications:A review [J]. J Adv Res,2015,6 (2):105-121.
  • 4GAO Y,XIE J,CHEN H,et al. Nanotechnology-based intelligent drug design for cancer metastasis treatment [J]. Biotechnol Adv,2014,32 (4):761-777.
  • 5DESALE S S,RAJA S M,KIM J O,et al. Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models [J]. J Controlled Release,2015,208(12):59-66.
  • 6YALLAPU M M,JAGGI M,CHAUHAN S C. Design and engineering of nanogels for cancer treatment [J]. Drug Discov Today,2011,16 (9-10):457-463.
  • 7LOU S,GAO S,WANG W,et al. Galactose-functionalized multi-responsive nanogels for hepatoma-targeted drug delivery [J]. Nanoscale,2015,7 (7):3137-3146.
  • 8HE H,CATTRAN A W,NGUYEN T,et al. Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery [J]. Biomaterials,2014,35 (35):9546-9553.
  • 9SWAIN J,MISHRA A K. 1-Naphthol as an ESPT fluorescent molecular probe for sensing thermotropic microenvironmental changes of pluronic F127 in aqueous media [J]. Phys Chem Chem Phys,2015,17 (26):16752-16759.
  • 10JOUNG Y K,JANG J Y,CHOI J H,et al. Heparin-conjugated pluronic nanogels as multi-drug nanocarriers for combination chemotherapy [J]. Mol Pharm,2013,10 (2):685-693.

同被引文献90

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部